Clinical Trials Browser

Phase 3 × INDUSTRY × Therapeutic Uses × Clear all

NCT06747455 2026-04-27

BCG for Therapeutic Use Phase Ⅲ Clinical Trial

Phase 3 Active not recruiting

Urinary Bladder Neoplasms

NCT06241755 2024-02-05

Clinical Trial for Evaluating the Efficacy and Safety of BCG for Therapeutic Use in the Prevention of Postoperative Recurrence of Medium/High-risk Non-muscle Invasive Bladder Cancer (NMIBC)

Phase 3 Recruiting

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms